The Pharma Data

DECEMBER 17, 2020

Cadavid will be responsible for the strategy, direction and execution of the company’s clinical development programs. Prior to Fulcrum, Cadavid held several leadership positions at Biogen, including Senior Medical Director of the multiple sclerosis clinical development group. Immune Regulation – U.K.-based

Development 52

Development Gene Therapy Engineer Life Science 52

pharmaphorum

APRIL 7, 2021

While the Darzalex revenues are due to fall this year because of Janssen’s interpretation of the agreement between the two companies, there are also other revenue streams. With other drugs in the pipeline too, van de Winkel said the company aims to continue to break new ground with next-generation antibody-based therapies.

Antibody 65

Antibody Life Science Development Regulation 65

XTalks

MAY 11, 2023

Wendy: RARE-X is now the data and research arm of Global Genes, the flagship patient organization representing rare, ultra-rare, and “n-of-one” patients. That mission is really important to me because I think it’s the only way we’re going to accelerate drug development in rare disease. Development is just the beginning.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Development 97

XTalks

MAY 6, 2022

In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinical trials. elluminate Clinical Trial Management System (CTMS) Insights.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

pharmaphorum

MARCH 12, 2021

Speakers at the NIHR’s recent virtual event for the pharma industry discussed best practices for bringing patient insights into research. They’re not having to travel to speak to researchers in person anymore,” he said. Likewise, we’ve got greater flexibility in being able to do research at a time of their choosing.

Trials 116

Trials Research Pharma Companies Clinical Trials 116

pharmaphorum

NOVEMBER 3, 2022

Beyond digital clinical measures, digital solutions are maturing to address major challenges facing clinical research and offer enormous promise to support the key performance indicators (KPIs) for every member of our industry. Pharma companies with more mature digital strategies are able to focus on questions of scale.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Medicine 80

Drug Discovery World

OCTOBER 7, 2022

Earlier this year, Cancer Research UK (CRUK) launched its innovation engine, Cancer Research Horizons, to streamline drug discovery through the combination of its commercial and therapeutics teams. RA: Could you tell us about Cancer Research Horizons? . This is about changing how we operate.

HR 52

HR Research Drugs Development 52

XTalks

SEPTEMBER 5, 2023

Xtalks spoke with Maria Reyes Boceta-Muñoz, Clinical Operations Head of Development R&D at GlaxoSmithKline in Spain, Portugal & Israel, to understand the current vaccine development climate and where the sector is headed. What are the major challenges you’re facing right now in vaccine development?

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

pharmaphorum

AUGUST 24, 2022

The Food and Drug Administration’s (FDA) draft guidance, Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Subgroups in Clinical Trials , recommends sponsors develop and submit a race and ethnicity diversity plan early in clinical development. Community-led. Collaborate.

Clinical Trials 95

Clinical Trials Clinical Trials Trials Development 95

pharmaphorum

MAY 7, 2021

This philosophy was behind Xperiome’s recent decision to split into two different functions – Raremark, a community where patients and carers can share their experiences of living with rare diseases, and Xperiome, which leverages those insights for pharma companies looking to develop drugs for these conditions. About the author.

Development 124

Development Pharma Companies Clinical Trials Clinical Trials 124

pharmaphorum

OCTOBER 10, 2022

Together, they developed a bold new awareness campaign to help drive awareness of the need for patients at risk of lung cancer to get screened. “We We then worked in partnership to co-create and develop the campaign. The pharma industry has an important role to play in the future of cancer treatment and research.

Development 90

Development Research Marketing Life Science 90

The Pharma Data

OCTOBER 14, 2020

AOP Orphan – AOP Orphan Pharmaceuticals took over the Viennese pharmaceutical company Amomed and the Luxembourgish health-tech company SciPharm. AOP anticipates new opportunities in Austria as a hub for research and business. All jobs have been maintained and the workforce has grown from about 220 to 350.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing Trials 52